HUP0102411A2 - Retinsav aktivitást gátló anyagok alkalmazása hajhullás lassítására - Google Patents

Retinsav aktivitást gátló anyagok alkalmazása hajhullás lassítására

Info

Publication number
HUP0102411A2
HUP0102411A2 HU0102411A HUP0102411A HUP0102411A2 HU P0102411 A2 HUP0102411 A2 HU P0102411A2 HU 0102411 A HU0102411 A HU 0102411A HU P0102411 A HUP0102411 A HU P0102411A HU P0102411 A2 HUP0102411 A2 HU P0102411A2
Authority
HU
Hungary
Prior art keywords
benzoic acid
acid
adamantyl
tetrahydro
tetramethyl
Prior art date
Application number
HU0102411A
Other languages
English (en)
Inventor
Jean-Daniel Doutremepuich
Carole Marconnet
Original Assignee
Galderma Research & Development, S.N.C.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma Research & Development, S.N.C. filed Critical Galderma Research & Development, S.N.C.
Publication of HUP0102411A2 publication Critical patent/HUP0102411A2/hu
Publication of HUP0102411A3 publication Critical patent/HUP0102411A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/603—Salicylic acid; Derivatives thereof having further aromatic rings, e.g. diflunisal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

A találmány retinsavaktivitást gátló anyag alkalmazására vonatkozikkozmetikai vagy gyógyszerészeti készítményekben a szőr- és/vagyhajnövekedés lassítására és/vagy gátlására vagy a szőr és/vagyhajhullás lassítására, ahol a retinsavaktivitást gátló inhibitorelőnyösen az alábbi vegyületek közül van kiválasztva: - 4-[7-(1-adamantil)-6-metoxietoximetoxi-2-naftil]-benzoesav, - 4-[7-(1-adamantil)-6-metoxietoximetoxi-2-naftil]-szalicilsav, - 6-[7-(1-adamantil)-6-metoxietoximetoxi-2-naftil]-nikotinsav, - 4-{[5,6-dihidro-5,5-dimetil-8-(4-metilfenil)-2-naftil]-etinil} benzoesav, -(E)-4-[2-(4,4-dimetil-7-heptiloxi-1,1-dioxo-3,4-dihidro-2H-1- -benzotiopirán-6-il)propenil]benzoesav, - 4-[4,5,7,8,9,10-hexahidro-7,7,10,10-tetrametil-1-(3-piridilme- til)antra[1,2-b]pirrol-3-il]benzoesav, - 4-[4,5,7,8,9,10-hexahidro-7,7,10,10-tetrametil-1-(3-piridilme- til)tioantra[1,2-b]pirrol-3-il]benzoesav, - 4-[4,5,7,8,9,10-hexahidro-7,7,10,10-tetrametil-1-(3-piridilme-til)antra[1,2-d]pirazol-3-il]benzoesav, - 4-[3-(diadamantil)-4-metoxibenzamido]benzoesav, - 4-[3-(diadamantil)-4-metoxibenzoyloxi]benzoesav, - 4-(N-fenil-5,6,7,8-tetrahidro-5,5,8,8-tetrametilnafto-[2,3-d]imi- dazol-2-il)benzoesav, - 4-(N-benzil-5,6,7,8-tetrahidro-5,5,8,8-tetrametil-nafto[2,3-d]imidazol-2-il)benzoesav, - 4-(5H-7,8,9,10-tetrahidro-5,7,7,10,10-pentametil-benzo[c]naf- to[2,3-b][1,4]diazepin-3-il)benzoesav, - 4-[1-(1-metoxi-2,2,2-trifluoroetil)-5,6,7,8-tetrahidro-5,5,8,8-tet- rametil-3-antracenil]benzoesav, - 4-(5,5-dimetil-8-fenil-5,6-dihidronaft-2-il-etinil)-benzoesav, - 4-(5,5-dimetil-8-p-tolil-5,6-dihidronaft-2-il-etinil)-benzoesav, - 4-[4-(bifenil-2-il)but-3-en-l-inil)benzoesav, -(E)-4-[[3-oxo-3-[3-(1-adamantil)-4-metoxietoxi-metoxifenil]- -1-propenil]]benzoesav. Ó
HU0102411A 1998-03-31 1999-03-24 Use of retinoic acid activity inhibitors to slow down hair loss HUP0102411A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9803978A FR2776511B1 (fr) 1998-03-31 1998-03-31 Utilisation dans ou pour la preparation d'une composition d'au moins un inhibiteur de l'activite de l'acide retinoique
PCT/FR1999/000687 WO1999049838A1 (fr) 1998-03-31 1999-03-24 Utilisation des inhibiteurs de l'activite de l'acide retinoique pour retarder la chute des cheveux

Publications (2)

Publication Number Publication Date
HUP0102411A2 true HUP0102411A2 (hu) 2001-11-28
HUP0102411A3 HUP0102411A3 (en) 2002-12-28

Family

ID=9524693

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0102411A HUP0102411A3 (en) 1998-03-31 1999-03-24 Use of retinoic acid activity inhibitors to slow down hair loss

Country Status (16)

Country Link
EP (1) EP1066017A1 (hu)
JP (1) JP2002509870A (hu)
KR (1) KR20010042104A (hu)
CN (1) CN1298290A (hu)
AR (1) AR015551A1 (hu)
AU (1) AU2938899A (hu)
BR (1) BR9908411A (hu)
CA (1) CA2324899A1 (hu)
FR (1) FR2776511B1 (hu)
HU (1) HUP0102411A3 (hu)
IL (1) IL137859A0 (hu)
NO (1) NO20004880L (hu)
PL (1) PL343004A1 (hu)
RU (1) RU2193877C2 (hu)
WO (1) WO1999049838A1 (hu)
ZA (1) ZA200004483B (hu)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2733684B1 (fr) * 1995-05-03 1997-05-30 Cird Galderma Utilisation de retinoides dans une composition cosmetique ou pour la fabrication d'une composition pharmaceutique
FR2739777B1 (fr) * 1995-10-11 1997-11-14 Cird Galderma Ligand antagoniste rar-gamma ou agoniste rar-alpha en tant qu'inhibiteur d'apoptose
US5965606A (en) * 1995-12-29 1999-10-12 Allergan Sales, Inc. Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity
AU723930B2 (en) * 1996-03-18 2000-09-07 Eisai R&D Management Co., Ltd. Fused-ring carboxylic acid derivatives

Also Published As

Publication number Publication date
RU2193877C2 (ru) 2002-12-10
HUP0102411A3 (en) 2002-12-28
NO20004880D0 (no) 2000-09-28
NO20004880L (no) 2000-11-30
PL343004A1 (en) 2001-07-30
IL137859A0 (en) 2001-10-31
ZA200004483B (en) 2002-02-27
EP1066017A1 (fr) 2001-01-10
CN1298290A (zh) 2001-06-06
CA2324899A1 (fr) 1999-10-07
BR9908411A (pt) 2000-12-05
AR015551A1 (es) 2001-05-02
KR20010042104A (ko) 2001-05-25
JP2002509870A (ja) 2002-04-02
AU2938899A (en) 1999-10-18
FR2776511B1 (fr) 2001-05-11
WO1999049838A1 (fr) 1999-10-07
FR2776511A1 (fr) 1999-10-01

Similar Documents

Publication Publication Date Title
HUP0203294A2 (hu) Benzodiazepinszármazékok, eljárás az előállításukra, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
UY24816A1 (es) Sulfonamidas agonistas de prostaglandinas para la prevención y restauración de la masa ósea
AR008638A1 (es) Utilizacion de un inhibidor de la actividad del acido retinoico en una composicion cosmetica o para la preparacion de una composicion farmaceutica
HUP0302287A2 (hu) Eljárás ciklopropánkarbonsav-észterek és származékaik előállítására
TNSN00231A1 (fr) Forme cristalline de 4-carboxyamino-2-substitue-1,2,3,4- tetrahydroquinoleine, et compositions la contenant
PL186821B1 (pl) Zastosowanie ligandu antagonistycznego RAR-gama i/lub ligandu agonistycznego RAR-alfa jako inhibitorów apoptozy
EP0749752B1 (fr) Utilisation de ligands spécifiques des récepteurs RXRs
BG104740A (en) Meta-azacyclic amino benzoic acid compounds and derivatives thereof being integrin antagonists
AU762364B2 (en) Assay for identification of compounds that promote melanin production and retinoid-like compounds identified by said assay
HUP0102411A2 (hu) Retinsav aktivitást gátló anyagok alkalmazása hajhullás lassítására
HUP0300298A2 (hu) 4-[Piperazinil-8-(kinolinil-metil)]benzamid-származékok, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
US20020052416A1 (en) Use of prostaglandin EP-3 receptor antagonists as cosmetic agents for attenuating, reducing or stopping the loss of head hair and other hairs
US5827500A (en) Process for identifying RAR-receptor-antagonist compounds
AU674479B2 (en) New compositions based on a synergistic mixture of at least one ligand specific for RXRs and at least one ligand specific for RAR-alpha, and their uses
ES2173408T3 (es) Dispersion acuosa de vesiculas resistentes a la deshidratacion.
ATE152442T1 (de) Substituierte arylalkylaminobenzyl- aminopropanamide, ihre herstellung und verwendung als antiepileptische, neuroprotektive und antidepressive mittel
KR101151481B1 (ko) 항주름제
RU95113115A (ru) Фармацевтическая композиция
ES2314111T3 (es) Monohidroxicarbamezepina para uso en la preparacion de un medicamento para el tratamiento del trastorno de afectivo y de atencion y dolor neuropatico.
AU772796B2 (en) Use of aromatic polycyclic compounds as activators of PPARs-type receptors in a cosmetic or pharmaceutical composition
BR0015404A (pt) Compostos relacionados com ácido 15-hidroxieicosatetraenóico e métodos de uso
RU2000127111A (ru) Агент для изменения роста волос в косметической или фармацевтической композиции, способ нетерапевтической обработки волос и набор
FR2817150B1 (fr) Utilisation de sterols en tant que principe actif dans une composition cosmetique pour lutter contre l'adiposite
Peiró et al. Pharmacological interference of vascular smooth muscle cell hypertrophy induced by glycosylated human oxyhaemoglobin
AU2002224337A1 (en) Use of hydroperoxyeicosatetraenoic acid derivatives following refractive surgery